Truist analyst Brian Foran raised the firm’s price target on Synchrony (SYF) to $77 from $72 and keeps a Buy rating on the shares. The firm is ...
Patients may think dentists are extending payment for costly procedures, but some could be steering clients to a high-interest credit card.
Synchrony Financial (NYSE: NYSE:SYF), a leading consumer financial services company, has demonstrated remarkable resilience in the face of regulatory challenges and economic uncertainties. As of ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Synchrony Financial partners with retailers and medical providers to offer promotional financing as well as private-label and co-branded general-purpose credit cards. While the company’s CareCredit ...
Fintel reports that on January 28, 2025, Compass Point downgraded their outlook for Synchrony Financial (NYSE:SYF) from Buy ...
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Synchrony ...